Linezolid-related Optic Nerve Disorders: Insight From a Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System. [PDF]
Nakano Y +4 more
europepmc +1 more source
Antibiotic dose-response curves can measure antibiotic activity against <i>Mycobacterium abscessus</i> and <i>Mycobacterium peregrinum</i>. [PDF]
Poonawala H +8 more
europepmc +1 more source
Off-target anti-leukemic effects of antibiotics: mechanisms and therapeutic insights. [PDF]
Charamis J +3 more
europepmc +1 more source
Identification of genetic mutations conferring tedizolid resistance in MRSA mutants. [PDF]
Goda NB +4 more
europepmc +1 more source
How to use novel antimicrobials beyond official indications: an expert consensus. [PDF]
Retamar-Gentil P +17 more
europepmc +1 more source
Omadacycline for the treatment of acute bacterial skin and skin structure infections: a systematic review and network meta-analysis. [PDF]
Kong WQ +5 more
europepmc +1 more source
Molecular basis of linezolid resistance in <i>Finegoldia</i> spp. from orthopedic infections. [PDF]
Jean-Pierre V +6 more
europepmc +1 more source
Methicillin-resistant <i>Staphylococcus aureus</i> and vancomycin-resistant <i>Enterococcus faecium</i> infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data and key evidence gaps. [PDF]
Gwee A +15 more
europepmc +1 more source
A Phase 3 Study of the Safety and Efficacy of Tedizolid Phosphate in Patients <12 Years of Age With Acute Bacterial Skin and Skin Structure Infections. [PDF]
Mngqibisa R +9 more
europepmc +1 more source
Non-tubercular mycobacterial infections: Emerging from the shadows. [PDF]
Mohan A, Suri T.
europepmc +1 more source

